Susquehanna International Group
VERA icon

Susquehanna International Group’s Vera Therapeutics VERA Stock Holding History

Susquehanna International Group’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.47M Buy
160,800
+99,200
+161% +$4.27M ﹤0.01% 3811
2025
Q4 		$3.12M Sell
61,600
-4,900
-7% -$174K ﹤0.01% 4810
2025
Q3 		$1.93M Sell
66,500
-328,500
-83% -$7.6M ﹤0.01% 5863
2025
Q2 		$9.31M Buy
395,000
+117,000
+42% +$2.63M ﹤0.01% 2929
2025
Q1 		$6.68M Buy
278,000
+254,000
+1,058% +$8.16M ﹤0.01% 3130
2024
Q4 		$1.01M Sell
24,000
-71,000
-75% -$3.14M ﹤0.01% 6908
2024
Q3 		$4.2M Buy
95,000
+55,200
+139% +$2.09M ﹤0.01% 3903
2024
Q2 		$1.44M Sell
39,800
-47,200
-54% -$1.87M ﹤0.01% 5758
2024
Q1 		$3.75M Buy
+87,000
New +$3.1M ﹤0.01% 4118
2023
Q4 		– Sell
-11,400
Closed -$156K – 13362
2023
Q3 		$156K Sell
11,400
-41,200
-78% -$707K ﹤0.01% 10508
2023
Q2 		$844K Buy
52,600
+34,700
+194% +$313K ﹤0.01% 7080
2023
Q1 		$139K Buy
+17,900
New +$138K ﹤0.01% 10988

Other funds holding VERA

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Susquehanna International Group's VERA Position: Q1 2026 in Review

Susquehanna International Group reduced its Vera Therapeutics (VERA) stake by 32% in Q1 2026, selling an estimated $2.4M and leaving 121,020 shares worth $4.87M. The position accounts for ﹤0.01% of the portfolio, ranked #4278.

Susquehanna International Group first reported a position in VERA in Q1 2023 and has held it in 13 quarters since. The position peaked at $8.95M in Q4 2025. 229 funds tracked by Wall St. Rank hold VERA as of Q1 2026.

  • Susquehanna International Group held 121,020 shares of Vera Therapeutics worth $4.87M as of Q1 2026.
  • Susquehanna International Group sold 55,664 Vera Therapeutics shares in Q1 2026, an estimated $2.4M.
  • Vera Therapeutics made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #4278 holding.
  • Susquehanna International Group first reported a position in Vera Therapeutics in Q1 2023 and has held it in 13 quarters since.
  • Susquehanna International Group's Vera Therapeutics position peaked at $8.95M in Q4 2025.
  • 229 funds tracked by Wall St. Rank held Vera Therapeutics as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.